Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immunotherapy Resistance”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02105675
What this trial is testing

Phase II Study of DCVAC/PCa Added to Standard Chemotherapy for Men With Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Prostate CancerProstate Cancer Metastatic
SOTIO a.s. 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT06939283
What this trial is testing

A Phase 1b/2 Multisite Dose-finding and Expansion Study of WTX-330 in Adult Patients With Selected Advanced or Metastatic Solid Tumors or Lymphoma

Who this might be right for
Advanced or Metastatic Solid TumorsNon-Hodgkin Lymphoma
Werewolf Therapeutics, Inc. 100
Not applicableUnknownNCT05906329
What this trial is testing

Low-dose Radiotherapy Combined With Conventional Fractionated Radiotherapy in Lung Cancer After Immunotherapy Resistance

Who this might be right for
Cancer Patients
Qianfoshan Hospital 20
Testing effectiveness (Phase 2)Looking for participantsNCT07063875
What this trial is testing

Adding IL-2 to Tebentafusp to Eradicate Cancer Progression

Who this might be right for
Uveal MelanomaMetastatic Uveal MelanomaMetastatic Uveal Melanoma in the Liver
St Vincent's Hospital, Sydney 8
Post-approval studies (Phase 4)Study completedNCT00329251
What this trial is testing

Study of the Influence of Vaccination in HIV Viral Load and Immunologic Responses Against HIV

Who this might be right for
HIV
Hospital Clinic of Barcelona 26
Very early researchNot Yet RecruitingNCT06364800
What this trial is testing

Allogeneic Gamma-delta T Cells Combined With Targeted Therapy and Immunotherapy in a Phase 1 Clinical Trial of Hepatocellular Carcinoma Resistant to PD-1 Monoclonal Antibody

Who this might be right for
Hepatocellular Carcinoma
Beijing 302 Hospital 18
Testing effectiveness (Phase 2)Study completedNCT05848011
What this trial is testing

Lorigerlimab With Docetaxel or Docetaxel Alone in Participants With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Androgen-Independent Prostatic CancerAndrogen-Independent Prostatic NeoplasmsProstate Cancer Recurrent+6 more
MacroGenics 154
Not applicableStudy completedNCT02694965
What this trial is testing

Understanding Immunotherapy Resistance Mechanisms in Advanced Melanoma

Who this might be right for
Melanoma
Duke University 122
Not applicableNot Yet RecruitingNCT07028866
What this trial is testing

Virus-associated Tumour Microenvironment: Characterisation and Immunological Mechanisms of Resistance to Anti-tumour Treatments

Who this might be right for
Lymphoma Cancer
Assistance Publique - Hôpitaux de Paris 254
Large-scale testing (Phase 3)Study completedNCT01909453
What this trial is testing

Study Comparing Combination of LGX818 Plus MEK162 Versus Vemurafenib and LGX818 Monotherapy in BRAF Mutant Melanoma

Who this might be right for
Melanoma
Pfizer 921
Early research (Phase 1)Looking for participantsNCT07813637
What this trial is testing

Phase 1 Trial to Study JANX013 and JANX007 Combination in mCRPC

Who this might be right for
Prostate CancerCastration-Resistant Prostate Cancer (CRPC)Metastatic Prostate Cancer+1 more
Janux Therapeutics 110
Very early researchUnknownNCT00790413
What this trial is testing

Haploidentical Stem Cell Transplantation in Neuroblastoma

Who this might be right for
Neuroblastoma
Lund University Hospital 15
Testing effectiveness (Phase 2)Study completedNCT01487863
What this trial is testing

Concurrent vs. Sequential Sipuleucel-T & Abiraterone Treatment in Men With Metastatic Castrate Resistant Prostate Cancer

Who this might be right for
Prostate Cancer MetastaticHormone Refractory Prostate CancerCastration-resistant Prostate Cancer
Dendreon 69
Testing effectiveness (Phase 2)Study completedNCT03262779
What this trial is testing

Ipilimumab and Nivolumab in Patients With Anti-PD-1-axis Therapy-resistant Advanced Non-small Cell Lung Cancer.

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Yale University 20
Testing effectiveness (Phase 2)WithdrawnNCT01530984
What this trial is testing

Ipilimumab and GMCSF Immunotherapy for Prostate Cancer

Who this might be right for
Prostate Cancer
Lawrence Fong
Early research (Phase 1)Study completedNCT02625857
What this trial is testing

Safety & Immunogenicity of JNJ-64041809, a Live Attenuated Double-deleted Listeria Immunotherapy, in Participants With Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Prostatic Neoplasms, Castration-Resistant
Janssen Research & Development, LLC 26
Early research (Phase 1)Ended earlyNCT03549000
What this trial is testing

A Phase I/Ib Study of NZV930 Alone and in Combination With PDR001 and /or NIR178 in Patients With Advanced Malignancies.

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)Triple Negative Breast Cancer (TNBC)Pancreatic Ductal Adenocarcinoma (PDAC)+4 more
Novartis Pharmaceuticals 127
Very early researchStudy completedNCT03131934
What this trial is testing

Immunotherapy With Tacrolimus Resistant EBV CTL for Lymphoproliferative Disease After Solid Organ Transplant

Who this might be right for
Post-transplant Lymphoproliferative DiseaseTransplant-Related Hematologic Malignancy
University College, London 4
Testing effectiveness (Phase 2)WithdrawnNCT05022394
What this trial is testing

Sapanisertib and Nivolumab for the Treatment of Stage I-IV Non-small Cell Lung Cancer in Patients Who Have Progressed on Prior PD-1/PD-L1 Inhibitor Therapy, I-OVERCOME Study

Who this might be right for
Lung Non-Small Cell CarcinomaRecurrent Lung Non-Small Cell CarcinomaStage I Lung Cancer AJCC v8+10 more
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07324473
What this trial is testing

Ivarmacitinib Combined With Camrelizumab and Apatinib for Unresectable Advanced Hepatocellular Carcinoma With Acquired Resistance to Immune Checkpoint Therapy: A Single-Arm Exploratory Clinical Study

Who this might be right for
Hepatocellular CarcinomasResistance to ImmunotherapyImmunomodulation+1 more
First Affiliated Hospital of Chongqing Medical University 65
Next Page